To receive your instant CME certificate, you must first "Sign In" or "Sign Up" in the top right corner.
ORIGINAL RELEASE: July 1, 2020
EXPIRATION: July 31, 2021
MAXIMUM CREDITS: 1.0 AMA PRA Category 1 Credit™
CLICK HERE TO PROCEED TO PROGRAM
LEARNING METHOD AND MEDIUM
This educational activity consists of a six (6)-question pretest, a webcast, and five (5) study questions. The participant should, in order, read the learning objectives, complete the pretest, view the webcast, answer all questions in the post test, and complete the evaluation. To receive credit for this activity, please complete the post test and evaluation. This educational activity should take a maximum of 1.0 hour to complete.
Provision of safe and efficacious treatments for patients with glaucoma who are challenged to adhere to topical treatment regimens or who need additional interventions when first-line options fail is an important unmet need. Both sustained drug delivery devices and minimally invasive glaucoma surgery (MIGS) techniques strive to meet that need. Several sustained drug delivery devices are currently under investigation, with some devices demonstrating encouraging results. Approved and investigational subconjunctival MIGS have been shown to reduce intraocular pressure substantially for most patients while relieving drop burden. Common side effects include postoperative needling, nonpersistent loss of best-corrected visual acuity, and transient hypotony. Several preoperative and perioperative strategies contribute to surgical success. This webcast captures a live CME symposium held during the 2020 Annual Meeting of the American Glaucoma Society. The desired results of this educational activity are for learners to improve their knowledge and competence regarding the potential role of sustained drug delivery systems and newer MIGS in improving visual outcomes for patients with glaucoma who are challenged to adhere to topical therapy.
This continuing medical education activity is provided by New York Eye and Ear Infirmary of Mount Sinai. This educational activity was developed and implemented in collaboration with MedEdicus LLC.
This continuing medical education activity is supported through an unrestricted educational grant from Allergan.
PROCEED TO PROGRAM